Essex Investment Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-5,729
Closed -$270K 544
2018
Q3
$270K Buy
+5,729
New +$270K 0.03% 360